Archive for August, 2008

Germany’s IQWiG prepares to test new cost-benefit methodology

Submitted by THE HEALTH ECONOMICS BLOG
The German health technology assessment institute, IQWiG, plans to begin testing the
latest version of its cost-benefit assessment methodology for medicines towards the end of September. The results of the testing, which will last for about four months, will be keenly awaited by pharmaceutical companies because IQWiG’s assessments will be used [...]

Health Economics Position in Europe: Director of Market Access, Pricing and Reimbursement in Belgium

Submitted by THE HEALTH ECONOMICS BLOG
Dear Readers,
please find below job posting that just came in. Interested individuals please contact Michael Lister (contact details below).
Cheers
Ulf
Location: Belgium
The Client is a late-stage biomedical company and operates at the cutting edge of regenerative medicine and focuses on the development of innovative local treatments for damaged and osteoarthritic joints.
Major Accountabilities:
• [...]

Senators Propose Nonprofit Institute to Study Comparative Effectiveness

Submitted by THE HEALTH ECONOMICS BLOG
published in “Quality”
Democratic Senate leaders July 31 introduced legislation that would create a comparative effectiveness institute dedicated to researching and disseminating information about which health care treatments work best, without evaluating cost or health plan design factors.
The proposed Comparative Effectiveness Research Act of 2008 (S. 3408) would establish the Health [...]